Micropaque (Barium Sulfate)

Barium sulfate, the active ingredient in Micropaque, is a contrast agent presented as a suspension for oral and rectal use. It creates radiopaque images of the gastrointestinal tract, enabling detailed visualization during diagnostic radiology procedures. It is commonly employed in radiographic examinations to assess the anatomy and function of the esophagus, stomach, small intestine and colon.

GNH USA supplies Micropaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Micropaque, a barium sulfate contrast agent, is used in radiographic imaging of the gastrointestinal tract. - Barium swallow (esophageal imaging): provides clear visualization of the esophagus to detect strictures, motility disorders or lesions. - Barium enema (colon imaging): outlines the colon and rectum for assessment of polyps, inflammation or structural abnormalities. - Upper gastrointestinal tract radiography: delineates the stomach and duodenum to evaluate ulcers, tumors or functional disorders.

Barium sulfate suspension may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild feeling of queasiness after ingestion. - Abdominal cramping: temporary discomfort in the stomach or intestines. - Diarrhea: loose stools occurring within hours of administration. - Constipation: difficulty passing bowel movements following the procedure. - Vomiting: occasional expulsion of the contrast material. - Taste disturbance: metallic or chalky sensation in the mouth.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling or anaphylaxis requiring immediate medical attention. - Aspiration: inhalation of the suspension into the lungs leading to respiratory distress. - Bowel perforation: rare tearing of the intestinal wall that may necessitate surgery. - Severe electrolyte imbalance: significant shifts in blood minerals after large volume administration.

Before using Micropaque, healthcare professionals should observe several precautionary measures to ensure patient safety. - Assess for bowel obstruction: confirm no known gastrointestinal blockage before administration. - Verify hypersensitivity: inquire about previous allergic reactions to barium or similar contrast agents. - Ensure adequate hydration: encourage fluid intake to facilitate passage of the suspension. - Avoid use in suspected perforation: contraindicated when intestinal perforation is suspected. - Use with caution in pregnancy: limited safety data; weigh diagnostic benefit against potential risk. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Barium sulfate can affect the absorption or effectiveness of certain orally administered medications, requiring attention to possible drug interactions.

Major Interactions (Avoid): - Tetracycline antibiotics: barium binds and markedly reduces absorption, compromising efficacy. - Fluoroquinolone antibiotics: concurrent use may lower drug bioavailability. - Iron supplements: barium interferes with iron absorption, diminishing therapeutic effect.

Moderate Interactions (Monitor Closely): - Levothyroxine (thyroid hormone): barium may decrease absorption; monitor thyroid function tests. - Other oral medications: timing of administration should be spaced at least 4 hours apart to avoid reduced uptake.